(Q46808804)

25 December 2017

title

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

Susan J Appel

1

1 reference

25 December 2017

Joanne S Harrell

series ordinal

2

1 reference

25 December 2017

Marsha L Davenport

series ordinal

3

1 reference

25 December 2017

publication date

1 December 2005

1 reference

25 December 2017

Journal of the American Academy of Nurse Practitioners

published in

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

535-541

1 reference

25 December 2017

Calculating insulin resistance in the primary care setting: why should we worry about insulin levels in euglycemic patients?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

African American women, metabolic syndrome, and national cholesterol education program criteria: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Central obesity and the metabolic syndrome: implications for primary care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Obesity, insulin resistance, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2005.00083.X

10.1111/J.1745-7599.2005.00083.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017